Consistent with this, it has been described that pioglitazone treatment up-regulates VEGF-A and eNOS expression, significantly ameliorates endothelial dysfunction, and enhances blood flow recovery after tissue ischemia in diabetic mice, via AKT phosphorylation (37). Here, VEGFA is linked to endothelial dysfunction.